|
|
Volumn 16, Issue 2, 2008, Pages 219-220
|
|
Why bother?: Is in utero gene therapy worth the effort?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PARVOVIRUS VECTOR;
RETROVIRUS VECTOR;
VIRUS VECTOR;
ABORTION;
ADENO ASSOCIATED VIRUS;
CARCINOGENESIS;
CLINICAL DECISION MAKING;
CLINICAL EFFECTIVENESS;
COMBINED IMMUNODEFICIENCY;
DISEASE SEVERITY;
EDITORIAL;
EQUINE INFECTIOUS ANEMIA VIRUS;
FERTILIZATION IN VITRO;
FETUS DEVELOPMENT;
FETUS MONITORING;
GENE EXPRESSION REGULATION;
GENE OVEREXPRESSION;
GENE THERAPY;
GENE TRANSFER;
GENE VECTOR;
GENETIC DISORDER;
GENETIC TRANSDUCTION;
GERM LINE GENE THERAPY;
HUMAN;
IN UTERO GENE THERAPY;
LIVER CELL CARCINOMA;
MURINE LEUKEMIA VIRUS;
MYELOPROLIFERATIVE DISORDER;
NONHUMAN;
PATIENT SAFETY;
POSTNATAL CARE;
POSTNATAL DEVELOPMENT;
PREGNANCY TERMINATION;
PREIMPLANTATION EMBRYO;
PRENATAL CARE;
PRENATAL DEVELOPMENT;
PRENATAL DIAGNOSIS;
PRENATAL SCREENING;
PRIMORDIAL GERM CELL;
RELIABILITY;
RISK BENEFIT ANALYSIS;
TISSUE INJURY;
TRANSGENE;
TREATMENT INDICATION;
|
|
EID: 38649118552
PISSN: 15250016
EISSN: 15250024
Source Type: Journal
DOI: 10.1038/sj.mt.6300401 Document Type: Editorial |
|
Times cited : (6)
|
|
References (0)
|